Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM)

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM)

BearDownAZ

May 06, 2019 09:12AM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM)

in response to

Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM)

BearDownAZ

posted on May 06, 2019 09:16AM

Here's some more background about the Resverlogix pulmonary arterial hypertension (PAH) program from a prior post. And here's the prior news release on the trial funding.